Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2019-10-30
DOI
10.1080/14656566.2019.1683161
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Word to the Wise About Intranasal Esketamine
- (2019) Alan F. Schatzberg AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- S114. Efficacy and Safety of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression
- (2018) Rachel Ochs-Ross et al. BIOLOGICAL PSYCHIATRY
- Intracellular Signaling Pathways Involved in ( S )- and ( R )-Ketamine Antidepressant Actions
- (2018) Panos Zanos et al. BIOLOGICAL PSYCHIATRY
- Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
- (2018) Somaye Arabzadeh et al. JOURNAL OF AFFECTIVE DISORDERS
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study
- (2018) Randall L. Morrison et al. PSYCHOPHARMACOLOGY
- The Promise of Intranasal Esketamine as a Novel and Effective Antidepressant
- (2018) Daniel S. Quintana et al. JAMA Psychiatry
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study
- (2018) Yoav Domany et al. BRITISH JOURNAL OF PSYCHIATRY
- Repeat-Dose Ketamine Augmentation for Treatment-Resistant Depression with Chronic Suicidal Ideation: A Randomized, Double Blind, Placebo Controlled Trial
- (2018) Dawn F. Ionescu et al. JOURNAL OF AFFECTIVE DISORDERS
- Antidepressant Potential of ( R )-Ketamine in Rodent Models: Comparison with ( S )-Ketamine
- (2017) Kenichi Fukumoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE
- (2016) William V. Bobo et al. DEPRESSION AND ANXIETY
- Ketamine: 50 Years of Modulating the Mind
- (2016) Linda Li et al. Frontiers in Human Neuroscience
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review
- (2015) Nicolas D. Iadarola et al. Therapeutic Advances in Chronic Disease
- A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
- (2014) Kyle A.B. Lapidus et al. BIOLOGICAL PSYCHIATRY
- Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression
- (2014) Paulo R. Shiroma et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Serial infusions of low-dose ketamine for major depression
- (2013) Keith G Rasmussen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
- (2013) Ji-chun Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Ketamine use: a review
- (2011) Celia J. A. Morgan et al. ADDICTION
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- Star-D: lessons learned and future implications
- (2011) A. John Rush DEPRESSION AND ANXIETY
- Intranasal delivery to the brain
- (2011) Robert I Henkin NATURE BIOTECHNOLOGY
- Stress and anxiety: Structural plasticity and epigenetic regulation as a consequence of stress
- (2011) Bruce S. McEwen et al. NEUROPHARMACOLOGY
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study
- (2009) Celia J. A. Morgan et al. ADDICTION
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Development of a Sublingual/Oral Formulation of Ketamine for Use in Neuropathic Pain
- (2009) Chui Chong et al. CLINICAL DRUG INVESTIGATION
- Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators
- (2008) Bruce S. McEwen EUROPEAN JOURNAL OF PHARMACOLOGY
- Comparison of racemic ketamine andS-ketamine in treatment-resistant major depression: Report of two cases
- (2008) Robert Paul et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started